Integra Lifesciences Holdings Corp (IART)
28.89
+0.14
(+0.49%)
USD |
NASDAQ |
May 03, 16:00
28.86
-0.03
(-0.10%)
After-Hours: 20:00
Integra Lifesciences Holdings Cash from Investing (Quarterly): -57.23M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -57.23M |
| September 30, 2023 | -7.697M |
| June 30, 2023 | -15.55M |
| March 31, 2023 | -13.70M |
| December 31, 2022 | -54.82M |
| September 30, 2022 | 14.80M |
| June 30, 2022 | -4.498M |
| March 31, 2022 | -14.07M |
| December 31, 2021 | -27.48M |
| September 30, 2021 | -8.475M |
| June 30, 2021 | -7.917M |
| March 31, 2021 | -117.57M |
| December 31, 2020 | -35.92M |
| September 30, 2020 | -6.718M |
| June 30, 2020 | -3.949M |
| March 31, 2020 | -21.48M |
| December 31, 2019 | -20.61M |
| September 30, 2019 | -108.84M |
| June 30, 2019 | -17.41M |
| March 31, 2019 | -15.81M |
| December 31, 2018 | -25.33M |
| September 30, 2018 | -16.34M |
| June 30, 2018 | 1.266M |
| March 31, 2018 | -9.298M |
| December 31, 2017 | -983.57M |
| Date | Value |
|---|---|
| September 30, 2017 | -7.107M |
| June 30, 2017 | -37.52M |
| March 31, 2017 | -193.14M |
| December 31, 2016 | -21.14M |
| September 30, 2016 | -6.707M |
| June 30, 2016 | -8.043M |
| March 31, 2016 | -6.73M |
| December 31, 2015 | -37.82M |
| September 30, 2015 | -315.45M |
| June 30, 2015 | -13.11M |
| March 31, 2015 | -5.632M |
| December 31, 2014 | -98.85M |
| September 30, 2014 | -8.775M |
| June 30, 2014 | -9.356M |
| March 31, 2014 | -246.34M |
| December 31, 2013 | -10.13M |
| September 30, 2013 | -13.39M |
| June 30, 2013 | -13.69M |
| March 31, 2013 | -13.09M |
| December 31, 2012 | -29.77M |
| September 30, 2012 | 19.86M |
| June 30, 2012 | -5.523M |
| March 31, 2012 | -63.84M |
| December 31, 2011 | -15.58M |
| September 30, 2011 | -80.86M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-117.57M
Minimum
Mar 2021
14.80M
Maximum
Sep 2022
-27.85M
Average
-15.55M
Median
Jun 2023
Cash from Investing (Quarterly) Benchmarks
| Stryker Corp | -408.00M |
| OraSure Technologies Inc | 30.55M |
| Insulet Corp | -31.60M |
| PROCEPT BioRobotics Corp | -1.946M |
| Perspective Therapeutics Inc | -0.089M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 58.75M |
| Cash from Financing (Quarterly) | -6.89M |
| Free Cash Flow | 73.09M |
| Free Cash Flow Per Share (Quarterly) | 0.4386 |
| Free Cash Flow to Equity (Quarterly) | 39.67M |
| Free Cash Flow to Firm (Quarterly) | 40.54M |
| Free Cash Flow Yield | 3.15% |